Change in Management

August 31, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE LTD. National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block, Bandra Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 SCRIP CODE: 543748 SYMBOL: AARTIPHARM Dear Sir/Madam, Sub.: Cessation of Senior Management Personnel of the Company Re.: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (“Listing Regulations”), we wish to inform that Shri G.M. Naidu, Manufacturing/ Sr. General Manager, Senior Management Personnel of the Company has tendered his resignation via email dated June 10, 2026 and will be relieved from the services of the Company with effect from the closure of business hours on August 31, 2026. The details as required under Regulation 30 read with Schedule III of the Listing Regulations and SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is given in Annexure A and resignation intimation email of Shri G.M. Naidu (Received on June 10, 2026) are enclosed. The above information is also available on the website of the Company: www.aartipharmalabs.com Please take the same on your records. Thanking you, Yours faithfully, For AARTI PHARMALABS LIMITED JEEVAN MONDKAR COMPANY SECRETARY AND LEGAL HEAD ICSI M. NO. A22565 Encl: a/a Annexure A Sr. No. Particulars Description 1. Name Shri G.M. Naidu 2. Reason for change viz. Resignation from the position of appointment, reappointment, Manufacturing/ Sr. General Manager, due to resignation, removal, death or his personal commitments otherwise 3. Date of cessation August 31, 2026 (relieving date) 4. Brief Profile (in case of Not Applicable appointment) 5. Disclosure of relationships Not Applicable between directors (in case of appointment of a director). On Wed, Jun 10, 2026 at 5:47 PM GM Naidu <gm.naidu@aartipharmalabs.com> wrote: I am writing to formally notify you of my resignation from the position of Chief of Operations with Aarti Pharma Labs. Following careful reflection, I have decided to step down from my role at Aarti Pharma Labs to move toward a direction that aligns more closely with my professional aspirations. I am thankful for the opportunities and experiences provided to me during my tenure at Aarti Pharma Labs. I deeply appreciate the valuable skills I have gained here, which will undoubtedly benefit my ongoing professional journey. Iam fully committed to assisting in ensuring a smooth transition. Sincerely, Naidu